UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 340.

A

Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; (2011) The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. SCIENCE , 334 (6052) pp. 89-94. 10.1126/science.1209202.

Agostinelli, C; Hartmann, S; Klapper, W; Korkolopoulou, P; Righi, S; Marafioti, T; Piccaluga, PP; (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. HISTOPATHOLOGY , 59 (4) pp. 679-691. 10.1111/j.1365-2559.2011.03981.x.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; Fagone, P; (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. NEUROBIOL DIS , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Gold open access

Amary, MF; Bacsi, K; Maggiani, F; Damato, S; Halai, D; Berisha, F; Pollock, R; (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J PATHOL , 224 (3) 334 - 343. 10.1002/path.2913.

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) pp. 1262-1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, Y; Colman, SM; Kempski, H; (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356-+. 10.1038/nature09650.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; Atra, A; (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arce, F; Breckpot, K; Collins, M; Escors, D; (2011) Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev , 7 (4) pp. 248-260. 10.2174/157339411797642605. Green open access
file

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. ARTHRITIS RHEUM-US , 63 (1) 84 - 95. 10.1002/art.30099.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) pp. 392-398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) pp. 832-840. 10.1002/cncr.25636.

Arrieta Bolanos, ER; Maldonado-Torres, H; Dimitriu, O; Hoddinott, MA; Fowles, F; Shah, A; Órlich-Pérez, P; (2011) HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley Population and its relationship to worldwide populations. Human Immunology , 72 (1) pp. 80-86. 10.1016/j.humimm.2010.10.005.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) pp. 295-305. 10.1007/s00439-011-1002-0.

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL

B

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; Sjoholm, R; (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; Davis, R; (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Banks, MR; Haidry, R; Butt, MA; Whitley, L; Stein, J; Langmead, L; Bloom, SL; (2011) High resolution colonoscopy in a bowel cancer screening program improves polyp detection. WORLD JOURNAL OF GASTROENTEROLOGY , 17 (38) pp. 4308-4313. 10.3748/wjg.v17.i38.4308. Gold open access

Bateman, A; Agrawal, S; Birney, E; Bruford, EA; Bujnicki, JM; Cochrane, G; Cole, JR; (2011) RNAcentral: A vision for an international database of RNA sequences. RNA , 17 (11) pp. 1941-1946. 10.1261/rna.2750811.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) pp. 16217-16222. 10.1073/pnas.1107692108.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; Flutter, B; (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. BLOOD , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Bennett, K; James, C; Mutair, A; Al-Shaikh, H; Sinani, A; Hussain, K; (2011) Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene. PEDIATRIC DIABETES , 12 (3) pp. 192-196. 10.1111/j.1399-5448.2010.00683.x.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; Tan, IB; (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) pp. 3447-3452. 10.1158/0008-5472.CAN-10-3667.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; Switzer, GE; (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Boshoff, C; (2011) Unraveling virus-induced lymphomagenesis. J CLIN INVEST , 121 (3) 838 - 841. 10.1172/JCI46499. Gold open access

Bouma, G; Mendoza-Naranjo, A; Blundell, MP; de Falco, E; Parsley, KL; Burns, SO; Thrasher, AJ; (2011) Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. BLOOD , 118 (9) 2492 - 2501. 10.1182/blood-2011-03-340265.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? NEPHROL DIAL TRANSPL , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; Costa-Cabral, S; (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) pp. 260-273. 10.1158/2159-8290.CD-11-0107.

Brown, NF; Marks, DJ; Smith, PJ; Bloom, SL; (2011) Splenomegaly. Br J Hosp Med (Lond) , 72 (11) M166-M169.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; Hartley, JA; (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

C

Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; Bose, F; (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) pp. 3669-3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; Drelichman, G; (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carpenter, L; Malladi, R; Yang, C-T; French, A; Pilkington, KJ; Forsey, RW; Sloane-Stanley, J; (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) pp. 4008-4011. 10.1182/blood-2010-08-299941.

Carrera-Marin, AL; Romay-Penabad, Z; Machin, S; Cohen, H; Weston-Davies, W; Pierangeli, SS; (2011) C5 Inhibitor rEV576 Ameliorates In Vivo Effects of Antiphospholipid Antibodies. In: (Proceedings) 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S5-S5). WILEY-BLACKWELL

Carrera-Marin, AL; Romay-Penabad, Z; Weston-Davis, W; Machin, S; Cohen, H; Pierangeli, SS; (2011) C5 inhibitor rEV576 ameliorates in vivo effects of antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 290.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Cheng, F; Pekkonen, P; Laurinavicius, S; Sugiyama, N; Henderson, S; Guenther, T; Rantanen, V; (2011) KSHV-Initiated Notch Activation Leads to Membrane-Type-1 Matrix Metalloproteinase-Dependent Lymphatic Endothelial-to-Mesenchymal Transition. CELL HOST & MICROBE , 10 (6) pp. 577-590. 10.1016/j.chom.2011.10.011.

Chua, MLK; Somaiah, N; A'Hern, R; Davies, S; Gothard, L; Yarnold, J; Rothkamm, K; (2011) Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. RADIOTHER ONCOL , 99 (3) 362 - 366. 10.1016/j.radonc.2011.05.071.

Chua, MLK; Somaiah, N; Bourne, S; Daley, F; A'Hern, R; Nuta, O; Davies, S; (2011) Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. RADIOTHER ONCOL , 99 (2) 225 - 230. 10.1016/j.radonc.2011.04.009.

Conde, L; Bracci, PM; Halperin, E; Skibola, CF; (2011) A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics , 98 (1) pp. 9-14. 10.1016/j.ygeno.2011.03.007.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) pp. 1409-1412. 10.1038/bmt.2010.323.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Counsell, N; Cortina-Borja, M; Lehtonen, A; Stein, A; (2011) Modelling psychiatric measures using Skew-Normal distributions. EUR PSYCHIAT , 26 (2) 112 - 114. 10.1016/j.eurpsy.2010.08.006.

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; Thompson, R; (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLINICAL CANCER RESEARCH , 17 (18) pp. 6083-6096. 10.1158/1078-0432.CCR-11-0945.

Cox, S.T.; (2011) The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome. Doctoral thesis, UCL (University College London). Green open access
file

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

D

Dancey, G.S.; (2011) Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents. Doctoral thesis, UCL (University College London). Green open access
file

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

De, S; Varsally, W; Falciani, F; Brogna, S; (2011) Ribosomal proteins' association with transcription sites peaks at tRNA genes in Schizosaccharomyces pombe. RNA , 17 (9) pp. 1713-1726. 10.1261/rna.2808411.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; Chi, KN; (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 364 (21) pp. 1995-2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; Luc, S; (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENETICS & CHROMATIN , 4 (ARTN 9) 10.1186/1756-8935-4-9. Gold open access

Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, Y; Pirzada, ZA; Eckert, MR; (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature , 471 (7340) pp. 602-607. 10.1038/nature09886.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; Zhang, Y; (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202-U618. 10.1053/j.gastro.2011.06.065.

Doebroessy, M; Klein, A; Janghra, N; Nikkhah, G; Dunnett, SB; (2011) Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease. JOURNAL OF NEUROSCIENCE METHODS , 197 (1) pp. 6-13. 10.1016/j.jneumeth.2011.01.015.

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; Delgado, J; (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; Prevost, T; (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Duhamel, L.A.E.; (2011) The role of LKB1 in the pathogenesis of Osteosarcoma. Doctoral thesis, UCL (University College London). Green open access
file

Dunn, JM; Banks, MR; Oukrif, D; Mackenzie, GD; Thorpe, S; Rodriguez-Justo, M; Winstanley, A; (2011) Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. ENDOSCOPY , 43 (7) 627 - 630. 10.1055/s-0030-1256443.

Dunn, JM; Hveem, T; Pretorius, M; Oukrif, D; Nielsen, B; Albregtsen, F; Lovat, LB; (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. BRIT J CANCER , 105 (8) 1218 - 1223. 10.1038/bjc.2011.353.

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Rodriguez-Justo, M; (2011) A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S215 - S216). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Winstanley, A; (2011) A RANDOMISED CONTROLLED TRIAL OF ALA VERSUS PHOTOFRIN PDT FOR HIGH GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A172 - A172). B M J PUBLISHING GROUP

Dunn, JM; McDonald, SA; Oukrif, D; Haidry, RJ; Butt, MA; Lovat, E; Lovat, LB; (2011) PLK-1 IS UPREGULATED IN BARRETT'S ADENOCARCINOMA AND IS A SURROGATE MARKER OF ANEUPLOIDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

E

El-Sharkawi, D; Basu, S; Qian, W; D'Sa, S; Hoskin, P; Ardeshna, K; (2011) LACTATE DEHYDROGENASE LEVELS DO NOT PREDICT RELAPSE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA. In: ANNALS OF ONCOLOGY. (pp. 223 - 223). OXFORD UNIV PRESS

El-Sharkawi, D; Ramsay, A; Cwynarski, K; Hughes, D; Prentice, A; Davies, N; Goode, A; (2011) Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. LEUKEMIA LYMPHOMA , 52 (11) 2130 - 2134. 10.3109/10428194.2011.589546.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; Hughes, DA; (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Endesfelder, D; McGranahan, N; Birkbak, NJ; Szallasi, Z; Kschischo, M; Graham, TA; Swanton, C; (2011) A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. ONCOTARGET , 2 (7) pp. 529-537.

Escors, D; Bricogne, C; Arce, F; Kochan, G; Karwacz, K; (2011) On the Mechanism of T cell receptor down-modulation and its physiological significance. J Biosci Med , 1 (1)

Evans, IM; Yamaji, M; Britton, G; Pellet-Many, C; Lockie, C; Zachary, IC; Frankel, P; (2011) Neuropilin-1 Signaling through p130(Cas) Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells. MOLECULAR AND CELLULAR BIOLOGY , 31 (6) pp. 1174-1185. 10.1128/MCB.00903-10.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

F

Feber, A; Wilson, GA; Zhang, L; Presneau, N; Idowu, B; Down, TA; Rakyan, VK; (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Research , 21 (4) pp. 515-524. 10.1101/gr.109678.110. Gold open access

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; Luketich, JD; (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; Whatcott, A; (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; Yiin, JJ; (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) pp. 4670-4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , 43 (1) pp. 47-59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. TRANSPLANTATION , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27.

Ferrer, IR; Araki, K; Ford, ML; (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant , 11 (4) pp. 654-659. 10.1111/j.1600-6143.2011.03473.x.

Ferrer, IR; Wagener, ME; Song, M; Kirk, AD; Larsen, CP; Ford, ML; (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A , 108 (51) pp. 20701-20706. 10.1073/pnas.1105500108.

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM pp. 231-237. 10.1182/asheducation-2011.1.231.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Chen, Y; Clapham, P; (2011) Ensembl 2011. Nucleic Acids Res , 39 (Database) D800-D806. 10.1093/nar/gkq1064.

Foroni, L; Wilson, G; Gerrard, G; Mason, J; Grimwade, D; White, HE; de Castro, DG; (2011) Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 153 (2) pp. 179-190. 10.1111/j.1365-2141.2011.08603.x.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, CJ; (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 302-306. 10.1038/nrclinonc.2011.42.

Furniss, D; Blandford, AE; Mayer, A; (2011) Considering Unremarkable Computing for Healthcare. Presented at: Workshop on Interactive Systems in Healthcare (WISH), Workshop at AMIA 2011 Annual Symposium.

Furniss, D; Blandford, AE; Rajkomar, A; Vincent, C; Mayer, A; (2011) The visible and the invisible: Distributed Cognition for medical devices. In: Blandford, A and De Pietro, G and Gallo, L and Gimblett, A and Oladimeji, P and Thimbleby, H, (eds.) EICS4Med 2011: Proceedings of the 1st International Workshop on Engineering Interactive Computing Systems for Medicine and Health Care: Pisa, Italy: June, 2011. (pp. pp. 1-6). CEUR Green open access
file

Furstenberg, A; Walsh, SB; Howie, A; Jones, G; Unwin, RJ; (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

G

Gadaleta, RM; Oldenburg, B; Willemsen, EC; Spit, M; Murzilli, S; Salvatore, L; Klomp, LW; (2011) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine. Biochim Biophys Acta , 1812 (8) pp. 851-858. 10.1016/j.bbadis.2011.04.005.

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

Germani, G; Hytiroglou, P; Fotiadu, A; Burroughs, AK; Dhillon, AP; (2011) Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update. SEMIN LIVER DIS , 31 (1) 82 - 90. 10.1055/s-0031-1272836.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; Szydlo, R; (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. AMERICAN JOURNAL OF HEMATOLOGY , 86 (3) pp. 313-315. 10.1002/ajh.21954.

Gillmore, R; Stuart, S; Kirkwood, A; Hameeduddin, A; Woodward, N; Burroughs, AK; Meyer, T; (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation. JOURNAL OF HEPATOLOGY , 55 (6) pp. 1309-1316.

Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; Woll, P; (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) pp. 138-152. 10.1016/j.ccr.2010.12.012.

Goh, V; Shastry, M; Engledow, A; Reston, J; Wellsted, DM; Peck, J; Endozo, R; (2011) Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. Eur Radiol , 21 (4) pp. 744-749. 10.1007/s00330-010-1967-4.

Golubnitschaja, O; Swanton, C; Danesi, R; Costigliola, V; (2011) Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J , 2 (2) pp. 131-136. 10.1007/s13167-011-0088-8.

Goold, HD; Escors, D; Conlan, TJ; Chakraverty, R; Bennett, CL; (2011) Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors. J IMMUNOL , 186 (8) 4565 - 4572. 10.4049/jimmunol.1002529. Gold open access

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; Kanki, JP; (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. LEUKEMIA , 25 (3) pp. 506-514. 10.1038/leu.2010.280.

Graham, TA; Humphries, A; Sanders, T; Rodriguez-Justo, M; Tadrous, PJ; Preston, SL; Novelli, MR; (2011) Use of methylation patterns to determine expansion of stem cell clones in human colon tissue. Gastroenterology , 140 (4) 1241-1250.e1-9-. 10.1053/j.gastro.2010.12.036.

Green, CL; Evans, CM; Zhao, L; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2011) The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. BLOOD , 118 (2) 409 - 412. 10.1182/blood-2010-12-322479.

Green, L; De Lord, C; Clark, B; Cadet, E; Rochette, J; Thein, SL; (2011) Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload. Br J Haematol , 154 (3) 288-. 10.1111/j.1365-2141.2011.08666.x.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Groves, AM; Shastry, M; Rodriguez-Justo, M; Malhotra, A; Endozo, R; Davidson, T; Kelleher, T; (2011) F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. EUR J NUCL MED MOL I , 38 (1) 46 - 52. 10.1007/s00259-010-1590-2.

Guerra, C; Collado, M; Navas, C; Schuhmacher, AJ; Hernández-Porras, I; Cañamero, M; Rodriguez-Justo, M; (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell , 19 (6) pp. 728-739. 10.1016/j.ccr.2011.05.011.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) pp. 7151-7157. 10.1016/j.bmc.2011.09.055.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; Payne, E; (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) pp. 1595-1603. 10.1084/jem.20101691.

Gutierrez-Gonzalez, L; Graham, TA; Rodriguez-Justo, M; Leedham, SJ; Novelli, MR; Gay, LJ; Ventayol-Garcia, T; (2011) The Clonal Origins of Dysplasia From Intestinal Metaplasia in the Human Stomach. GASTROENTEROLOGY , 140 (4) 1251-+. 10.1053/j.gastro.2010.12.051.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) pp. 1588-1599. 10.1002/glia.21201.

H

Hackshaw, A; Kirkwood, A; (2011) Interpreting and reporting clinical trials with results of borderline significance. BMJ , 343 d3340-.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; Enver, T; (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 580). AMER SOC HEMATOLOGY

Hall, A; Isgro, G; Morris, R; Burroughs, AK; Dhillon, AP; (2011) SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S133-S133). ELSEVIER SCIENCE BV

Harding, J.; (2011) Small RNAs as regulators of early vertebrate development. Doctoral thesis, UCL (University College London). Green open access
file

Harrison, JD; Rodriguez-Justo, M; (2011) Commentary on IgG4-related sialadenitis: Mikulicz's disease, Küttner's tumour, and eponymy. Histopathology , 58 (7) pp. 1164-1166. 10.1111/j.1365-2559.2011.03824.x.

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; Machin, S; (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 930-931.

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartmann, S; Agostinelli, C; Klapper, W; Korkolopoulou, P; Koch, K; Marafioti, T; Piccaluga, PP; (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? HISTOPATHOLOGY , 59 (6) pp. 1173-1182. 10.1111/j.1365-2559.2011.04069.x.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; Vanhaesebroeck, B; (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) pp. 278-287. 10.1016/j.jaut.2011.02.006.

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Herzog, B; Pellet-Many, C; Britton, G; Hartzoulakis, B; Zachary, IC; (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell , 22 (15) 2766 - 2776. 10.1091/mbc.E09-12-1061. Green open access
file

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; (2011) RITUXIMAB PLUS CHLORAMBUCIL (R-CHLORAMBUCIL) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): FINAL ANALYSIS OF AN OPEN-LABEL PHASE II STUDY. In: ANNALS OF ONCOLOGY. (pp. 123 - 123). OXFORD UNIV PRESS

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; Krystal, G; (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) pp. 866-875. 10.1016/j.cellsig.2011.01.012.

Hollenbach, JA; Mack, SJ; Gourraud, P-A; Single, RM; Maiers, M; Middleton, D; Thomson, G; (2011) A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. TISSUE ANTIGENS , 78 (5) pp. 333-344. 10.1111/j.1399-0039.2011.01777.x.

Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

I

Ibrahim, AR; Eliasson, L; Apperley, JF; Milojkovic, D; Bua, M; Szydlo, R; Mahon, F-X; (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. BLOOD , 117 (14) pp. 3733-3736. 10.1182/blood-2010-10-309807.

Isgro, G; Andreana, L; Garcovich, M; Luong, TV; Hall, A; Manousou, P; Goossens, N; (2011) COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S69-S70). ELSEVIER SCIENCE BV

Isgro, G; Hall, AR; Andreana, L; Luong, T; Burroughs, AK; Dhillon, AP; (2011) EDITED AND NON-EDITED COLLAGEN PROPORTIONATE AREA: PREDICTION OF DECOMPENSATION IN CIRRHOSIS. In: HEPATOLOGY. (pp. 1276A - 1276A). WILEY-BLACKWELL

J

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Jiao, Y; Lawler, K; Patel, GS; Purushotham, A; Jones, AF; Grigoriadis, A; Tutt, A; (2011) DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC BIOINFORMATICS , 12 (ARTN 403) 10.1186/1471-2105-12-403. Gold open access

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; Whelan, J; (2011) Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (34) pp. 4534-4540. 10.1200/JCO.2010.33.0670.

K

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kapoor, RR; Flanagan, SE; James, CT; McKiernan, J; Thomas, AM; Harmer, SC; Shield, JP; (2011) Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia , 54 (10) pp. 2575-2583. 10.1007/s00125-011-2207-4. Green open access
file

Karwacz, K; Bricogne, C; MacDonald, D; Arce, F; Bennett, CL; Collins, M; Escors, D; (2011) PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells. EMBO MOL MED , 3 (10) 581 - 592. 10.1002/emmm.201100165. Gold open access

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access
file

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Keane, TM; Goodstadt, L; Danecek, P; White, MA; Wong, K; Yalcin, B; Heger, A; (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature , 477 (7364) pp. 289-294. 10.1038/nature10413.

Khan, MS; El-Khouly, F; Davies, P; Toumpanakis, C; Caplin, ME; (2011) Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 34 (2) pp. 235-242. 10.1111/j.1365-2036.2011.04693.x.

Khan, MS; El-Khouly, F; Quigley, AM; Caplin, M; Toumpanakis, C; (2011) Y90-DOTATATE in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Survival following Different Indications for Treatment. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, T; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Rashid, M; Rabouhans, JS; Yu, D; Tu, VL; Caplin, M; (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant , 46 (1) pp. 10-13. 10.1038/bmt.2010.37.

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; Roughton, M; (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; Hart, SL; (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; Hirose, M; (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23-. 10.1126/scisignal.2001617.

L

Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) pp. 324-333.

Lambrianides, A; Turner-Stokes, T; Pericleous, C; Ehsanullah, J; Papadimitraki, E; Poulton, K; Ioannou, Y; (2011) Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis. ARTHRITIS AND RHEUMATISM , 63 (11) pp. 3512-3521. 10.1002/art.30525.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; Dafou, D; (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) pp. 1540-1549. 10.1093/carcin/bgr140.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Lawson, AR; Hindley, GF; Forshew, T; Tatevossian, RG; Jamie, GA; Kelly, GP; Neale, GA; (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res , 21 (4) pp. 505-514. 10.1101/gr.115782.110.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; Earl, H; (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; McNeish, I; (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. EUROPEAN JOURNAL OF CANCER , 47 S104-S115.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; Downward, J; (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) pp. 1858-1870. 10.1158/0008-5472.CAN-10-3604.

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; Kheradpour, P; (2011) A high-resolution map of human evolutionary constraint using 29 mammals. NATURE , 478 (7370) pp. 476-482. 10.1038/nature10530.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; Green, T; (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists Thyroid Fine-Needle Aspiration Diagnostic Classification Is a Robust Tool for the Clinical Management of Abnormal Thyroid Nodules. ACTA CYTOLOGICA , 55 (6) pp. 499-506. 10.1159/000333234.

Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; Yang, SP; (2011) Comparative and demographic analysis of orang-utan genomes. Nature , 469 (7331) pp. 529-533. 10.1038/nature09687.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; Twigger, K; (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) pp. 581-588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; Aguillon, JC; (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; Mead, AJ; (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1011). AMER SOC HEMATOLOGY

M

Ma, GL; Dhillon, AP; Hall, AR; Burroughs, AK; Tsochatzis, E; Burgess, G; Guo, F; (2011) ISHAK STAGE PROGRESSION RATE MODELING FOR POST LIVER TRANSPLANT (POLT) PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION. In: HEPATOLOGY. (pp. 579A - 579A). WILEY-BLACKWELL

Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; (2011) Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. BLOOD CELLS MOLECULES AND DISEASES , 47 (3) pp. 166-175. 10.1016/j.bcmd.2011.07.002.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; Dragovich, T; (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; Burnell, M; (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mandeville, H.C.; (2011) Exploration of the clinical interaction between vascular targeting agents and radiotherapy. Doctoral thesis, UCL (University College London). Green open access
file

Manousou, P; Dhillon, AP; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Xirouchakis, E; (2011) Digital Image Analysis of Liver Collagen Predicts Clinical Outcome of Recurrent Hepatitis C Virus 1 Year After Liver Transplantation. LIVER TRANSPLANT , 17 (2) 178 - 188. 10.1002/lt.22209.

Manousou, P; Kalambokis, G; Grillo, F; Watkins, J; Xirouchakis, E; Pleguezuelo, M; Leandro, G; (2011) Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. LIVER INT , 31 (5) 730 - 739. 10.1111/j.1478-3231.2011.02488.x.

Mansour, MR; Look, AT; (2011) Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma. CANCER CELL , 20 (5) pp. 559-561. 10.1016/j.ccr.2011.10.027.

Marsh, D; Suchak, K; Moutasim, KA; Vallath, S; Hopper, C; Jerjes, W; Upile, T; (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Marsh, D.J.; (2011) The αvβ6 Integrin in cancer. Doctoral thesis, UCL (University College London). Green open access
file

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2010. TISSUE ANTIGENS , 77 (2) pp. 167-175. 10.1111/j.1399-0039.2010.01595.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update February 2011. TISSUE ANTIGENS , 77 (6) pp. 613-617. 10.1111/j.1399-0039.2011.01688.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update January 2011. TISSUE ANTIGENS , 77 (6) pp. 603-612. 10.1111/j.1399-0039.2011.01687.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update November 2010. TISSUE ANTIGENS , 77 (4) pp. 355-361. 10.1111/j.1399-0039.2011.01643.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update October 2010. TISSUE ANTIGENS , 77 (4) pp. 349-354. 10.1111/j.1399-0039.2011.01644.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2010. TISSUE ANTIGENS , 77 (3) pp. 268-270. 10.1111/j.1399-0039.2010.01604.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2011. TISSUE ANTIGENS , 78 (6) pp. 482-484. 10.1111/j.1399-0039.2011.01797.x.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; Mcintosh, J; (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; Idziaszczyk, S; (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) pp. 2103-2114. 10.1016/S0140-6736(11)60613-2.

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) pp. 2845-2856. 10.1210/en.2010-1256.

McCaughan, F; Pipinikas, CP; Janes, SM; George, PJ; Rabbitts, PH; Dear, PH; (2011) Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia. J PATHOL , 224 (2) 153 - 159. 10.1002/path.2887.

Mellars, G; Gomez, K; (2011) Mutation detection by Southern blotting. Methods Mol Biol , 688 pp. 281-291. 10.1007/978-1-60761-947-5_19.

Mendoza-Naranjo, A; Bouma, G; Pereda, C; Ramirez, M; Webb, KF; Tittarelli, A; Lopez, MN; (2011) Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation. J IMMUNOL , 187 (6) 3121 - 3132. 10.4049/jimmunol.1100378.

Menezes, LJ; Kotze, CW; Agu, O; Richards, T; Brookes, J; Goh, VJ; Rodriguez-Justo, M; (2011) Investigating Vulnerable Atheroma Using Combined F-18-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation. J NUCL MED , 52 (11) 1698 - 1703. 10.2967/jnumed.111.093724.

Milojkovic, D; Apperley, JF; Ibrahim, AR; Bua, M; Reid, A; Gerrard, G; Foroni, L; (2011) Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 1613-1614). AMER SOC HEMATOLOGY

Milojkovic, D; Gerrard, G; Paliompeis, C; Bua, M; Reid, A; Alikian, M; Khorashad, J; (2011) The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for 'Stopping' Studies. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 278). AMER SOC HEMATOLOGY

Milojkovic, D; Ibrahim, AR; Foroni, L; Lucas, C; Gerrard, G; Wang, L; Szydlo, RM; (2011) Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 729). AMER SOC HEMATOLOGY

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; Evans, S; (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Morris, C; Cook, G; Streetly, M; Kettle, P; Drake, M; Quinn, M; Cavet, J; (2011) Re-transplantation after bortezomib-based therapy. BRITISH JOURNAL OF HAEMATOLOGY , 153 (5) pp. 666-668. 10.1111/j.1365-2141.2010.08521.x.

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; Kwiatkowski, JL; (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

Myers, RM; Stamatoyannopoulos, J; Snyder, M; Dunham, I; Hardison, RC; Bernstein, BE; Gingeras, TR; (2011) A user's guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biology , 9 (4) , Article e1001046. 10.1371/journal.pbio.1001046. Green open access
file

N

Naqvi, N; Davidson, SJ; Wong, D; Cullinan, P; Roughton, M; Doughty, VL; Franklin, RC; (2011) Predicting 22q11.2 deletion syndrome: a novel method using the routine full blood count. Int J Cardiol , 150 (1) pp. 50-53. 10.1016/j.ijcard.2010.02.027.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; Nawathe, S; (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Linch, DC; Chowdary, P; (2011) Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B. NEW ENGLAND JOURNAL OF MEDICINE , 365 (25) pp. 2357-2365. 10.1056/NEJMoa1108046.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, JH; Linch, DC; Chowdary, P; (2011) Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B. BLOOD , 118 (21) pp. 4-5.

Navani, N; Booth, HL; Kocjan, G; Falzon, M; Capitanio, A; Brown, JM; Porter, JC; (2011) Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. RESPIROLOGY , 16 (3) 467 - 472. 10.1111/j.1440-1843.2011.01933.x.

Navani, N; Nankivell, M; Nadarajan, P; Pereira, SP; Kocjan, G; Janes, SM; (2011) The learning curve for EBUS-TBNA. THORAX , 66 (4) 352 - 353. 10.1136/thx.2010.146407.

Navani, N; Nankivell, M; Woolhouse, I; Harrison, RN; Munavvar, M; Oltmanns, U; Falzon, M; (2011) Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy A Multicenter Study. J THORAC ONCOL , 6 (9) 1505 - 1509. 10.1097/JTO.0b013e318223c3fe.

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; Forni, GL; (2011) Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 315-316). AMER SOC HEMATOLOGY

Nicolaides, TP; Li, H; Solomon, DA; Hariono, S; Hashizume, R; Barkovich, K; Baker, SJ; (2011) Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res , 17 (24) pp. 7595-7604. 10.1158/1078-0432.CCR-11-1456.

O

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access

P

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; Arkenau, HT; (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) pp. 1561-1570. 10.1158/1078-0432.CCR-10-1927.

Partridge, L; Alic, N; Bjedov, I; Piper, MDW; (2011) Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Experimental Gerontology , 46 (5) 376 - 381. 10.1016/j.exger.2010.09.003. Green open access
file

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; Steele, AJ; (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Paul, DS; Nisbet, JP; Yang, TP; Meacham, S; Rendon, A; Hautaviita, K; Tallila, J; (2011) Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet , 7 (6) , Article e1002139. 10.1371/journal.pgen.1002139. Green open access
file

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; Stone, R; (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. BLOOD , 118 (4) pp. 903-915. 10.1182/blood-2010-11-318022.

Peggs, KS; Kayani, I; Edwards, N; Kottaridis, P; Goldstone, AH; Linch, DC; Hough, R; (2011) Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (8) 971 - 978. 10.1200/JCO.2010.32.1711.

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; Pang, K; (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green open access
file

Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; Carey, MS; (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 365 (26) pp. 2484-2496. 10.1056/NEJMoa1103799.

Pitt, K; James, C; Kochar, IS; Kapoor, A; Jain, S; Hussain, K; Bennett, K; (2011) A single base-pair deletion in the WFS1 gene causes Wolfram syndrome. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , 24 (5-6) pp. 389-391. 10.1515/JPEM.2011.215.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; Tilby, MJ; (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Poiroux, G; Pitié, M; Culerrier, R; Lafont, E; Ségui, B; Van Damme, EJ; Peumans, WJ; (2011) Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy. PLoS One , 6 (8) , Article e23315. 10.1371/journal.pone.0023315. Green open access
file

Popat, R; Dickson, J; Khan, I; Cheesman, S; Percy, L; Moore, S; D'Sa, S; (2011) An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1797). AMER SOC HEMATOLOGY

Porakishvili, N; Memon, A; Vispute, K; Kulikova, N; Clark, EA; Rai, KR; Nathwani, A; (2011) CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 153 (4) 486 - 498. 10.1111/j.1365-2141.2011.08605.x.

Pors, K; Loadman, PM; Shnyder, SD; Sutherland, M; Sheldrake, HM; Guino, M; Kiakos, K; (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Porter, JB; Lin, KH; Beris, P; Forni, GL; Taher, A; Habr, D; Domokos, G; (2011) Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. EUR J HAEMATOL , 87 (4) 338 - 348. 10.1111/j.1600-0609.2011.01660.x. Gold open access

Presneau, N; Shalaby, A; Ye, HT; Pillay, N; Halai, D; Idowu, B; Tirabosco, R; (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J PATHOL , 223 (3) 327 - 335. 10.1002/path.2816.

Proctor, IE; McNamara, C; Rodriguez-Justo, M; Isaacson, PG; Ramsay, A; (2011) Importance of Expert Central Review in the Diagnosis of Lymphoid Malignancies in a Regional Cancer Network. J CLIN ONCOL , 29 (11) 1431 - 1435. 10.1200/JCO.2010.31.2223.

Puzanov, I; Lee, W; Chen, AP; Calcutt, MW; Hachey, DL; Vermeulen, WL; Spanswick, VJ; (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

Q

Quezada, SA; Peggs, KS; (2011) Tumor-reactive CD4(+) T cells: plasticity beyond helper and regulatory activities. IMMUNOTHERAPY-UK , 3 (8) 915 - 917. 10.2217/IMT.11.83.

Quezada, SA; Peggs, KS; Simpson, TR; Allison, JP; (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. IMMUNOL REV , 241 104 - 118. 10.1111/j.1600-065X.2011.01007.x.

Quinn, J; Glassford, J; Percy, L; Munson, P; Marafioti, T; Rodriguez-Justo, M; Yong, K; (2011) APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. BLOOD , 117 (3) pp. 890-901. 10.1182/blood-2010-01-264424.

R

Raj, D; Davidoff, AM; Nathwani, AC; (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. EXPERT REV HEMATOL , 4 (5) 539 - 549. 10.1586/EHM.11.48.

Raja, FA; Griffin, CL; Qian, W; Hirte, H; Parmar, MK; Swart, AM; Ledermann, JA; (2011) Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer. BRIT J CANCER , 105 (7) 884 - 889. 10.1038/bjc.2011.334.

Rakyan, VK; Beyan, H; Down, TA; Hawa, MI; Maslau, S; Aden, D; Daunay, A; (2011) Identification of Type 1 Diabetes-Associated DNA Methylation Variable Positions That Precede Disease Diagnosis. PLOS GENET , 7 (9) , Article e1002300. 10.1371/journal.pgen.1002300. Green open access
file

Rakyan, VK; Down, TA; Balding, DJ; Beck, S; (2011) Epigenome-wide association studies for common human diseases. NAT REV GENET , 12 (8) 529 - 541. 10.1038/nrg3000.

Rani, A; Afzali, B; Kelly, A; Tewolde-Berhan, L; Hackett, M; Kanhere, AS; Pedroza-Pacheco, I; (2011) IL-2 Regulates Expression of C-MAF in Human CD4 T Cells. JOURNAL OF IMMUNOLOGY , 187 (7) pp. 3721-3729. 10.4049/jimmunol.1002354.

Reid, JM; Buhrow, SA; Kuffel, MJ; Jia, L; Spanswick, VJ; Hartley, JA; Thurston, DE; (2011) Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. CANCER CHEMOTH PHARM , 68 (3) 777 - 786. 10.1007/s00280-010-1517-4.

Renfree, MB; Papenfuss, AT; Deakin, JE; Lindsay, J; Heider, T; Belov, K; Rens, W; (2011) Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development. Genome Biol , 12 (8) R81-. 10.1186/gb-2011-12-8-r81. Green open access
filefilefilefilefile

Riddell, A; Abdul-Kadir, R; Pollard, D; Tuddenham, E; Gomez, K; (2011) Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb.Haemost. , 106 (3) 521 - 527.

Ringwald, M; Iyer, V; Mason, JC; Stone, KR; Tadepally, HD; Kadin, JA; Bult, CJ; (2011) The IKMC web portal: a central point of entry to data and resources from the International Knockout Mouse Consortium. NUCLEIC ACIDS RES , 39 D849 - D855. 10.1093/nar/gkq879. Gold open access

Rizzi, M; Neumann, C; Fielding, AK; Marks, R; Goldacker, S; Thaventhiran, J; Tarzi, MD; (2011) Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 128 (6) 1371-U783. 10.1016/j.jaci.2011.07.055.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2011) The IMGT/HLA database. NUCLEIC ACIDS RESEARCH , 39 D1171-D1176. 10.1093/nar/gkq998.

Roddie, C; Peggs, KS; (2011) Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. EXPERT OPIN BIOL TH , 11 (4) 473 - 487. 10.1517/14712598.2011.554811.

Roylance, R; Endesfelder, D; Gorman, P; Burrell, RA; Sander, J; Tomlinson, I; Hanby, AM; (2011) Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev , 20 (10) pp. 2183-2194. 10.1158/1055-9965.EPI-11-0343.

S

Salomoni, P; (2011) KAPping PML nuclear body number. CELL CYCLE , 10 (5) 735 - 736. 10.4161/cc.10.5.14927.

Salomoni, P; Betts-Henderson, J; (2011) The Role of PML in the Nervous System. MOL NEUROBIOL , 43 (2) 114 - 123. 10.1007/s12035-010-8156-y.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; Northen, JS; (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Scaffidi, P; Misteli, T; (2011) In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol , 13 (9) pp. 1051-1061. 10.1038/ncb2308.

Schaller, T; Ocwieja, KE; Rasaiyaah, J; Price, AJ; Brady, TL; Roth, SL; Hué, S; (2011) HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog , 7 (12) , Article e1002439. 10.1371/journal.ppat.1002439. Green open access
file

Scully, M; McDonald, V; Cavenagh, J; Hunt, BJ; Longair, I; Cohen, H; Machin, SJ; (2011) A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura. BLOOD , 118 (7) 1746 - 1753. 10.1182/blood-2011-03-341131.

Serrano, AE; Menares-Castillo, E; Garrido-Tapia, M; Ribeiro, CH; Hernandez, CJ; Mendoza-Naranjo, A; Gatica-Andrades, M; (2011) Interleukin 10 decreases MICA expression on melanoma cell surface. IMMUNOL CELL BIOL , 89 (3) 447 - 457. 10.1038/icb.2010.100.

Setty, S; Reddell, A; England, A; Gomez, K; Kadir, R; (2011) The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency. Haemophilia , 17 (6) pp. 906-909. 10.1111/j.1365-2516.2011.02525.x.

Shaw, BE; Apperley, JF; Russell, NH; Craddock, C; Liakopoulou, E; Potter, MN; Wynn, R; (2011) Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. BRIT J HAEMATOL , 153 (2) 244 - 252. 10.1111/j.1365-2141.2011.08615.x.

Shaw, BE; Confer, DL; Hwang, WY; Pamphilon, DH; Pulsipher, MA; (2011) Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. HAEMATOL-HEMATOL J , 96 (7) 942 - 947. 10.3324/haematol.2011.045740. Gold open access

Shiltagh, N; Hansen, FD; Gomez, K; Perkins, SJ; Tuddenham, EGD; (2011) Reassignment of the modular architecture of von Willebrand factor: novel structural insights into the non-a repeat region revealing the major FVIII binding region. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 661-662.

Short, SC; Giampieri, S; Worku, M; Alcaide-German, M; Sioftanos, G; Bourne, S; Lio, KI; (2011) Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+tumor-derived cells. NEURO-ONCOLOGY , 13 (5) pp. 487-499. 10.1093/neuonc/nor010.

Siddiqui, GK; Maclean, AB; Elmasry, K; Fong, AWT; Morris, RW; Rashid, M; Begent, RHJ; (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Siddle, HV; Deakin, JE; Coggill, P; Whilming, L; Harrow, J; Kaufman, J; Beck, S; (2011) The tammar wallaby major histocompatibility complex shows evidence of past genomic instability. BMC GENOMICS , 12 , Article 421. 10.1186/1471-2164-12-421. Green open access
file

Simmonds, N; Bates, AW; (2011) Reporting Paneth Cell Metaplasia in Paediatric GI Biopsies: An Audit on Current Practice and Review of Guidelines. In: JOURNAL OF PATHOLOGY. (pp. S19 - S19). WILEY-BLACKWELL

Siomi, MC; Sato, K; Pezic, D; Aravin, AA; (2011) PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol , 12 (4) pp. 246-258. 10.1038/nrm3089.

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; Guerro-Urbano, T; (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smedby, KE; Foo, JN; Skibola, CF; Darabi, H; Conde, L; Hjalgrim, H; Kumar, V; (2011) GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet , 7 (4) , Article e1001378. 10.1371/journal.pgen.1001378.

Smith, SW; Eardley, KS; Croft, AP; Nwosu, J; Howie, AJ; Cockwell, P; Isacke, CM; (2011) CD248(+) stromal cells are associated with progressive chronic kidney disease. KIDNEY INTERNATIONAL , 80 (2) pp. 200-208. 10.1038/ki.2011.103.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; Giardina, PJ; (2011) Quality of life in Thalassemia: A comparison of SF-36 results from the Thalassemia longitudinal cohort to reported literature and the US norms. AM J HEMATOL , 86 (1) 92 - 95. 10.1002/ajh.21896.

Sofueva, S; Osman, F; Lorenz, A; Steinacher, R; Castagnetti, S; Ledesma, J; Whitby, MC; (2011) Ultrafine anaphase bridges, broken DNA and illegitimate recombination induced by a replication fork barrier. Nucleic Acids Research , 39 (15) 6568- 6584. 10.1093/nar/gkr340. Green open access
file

Starke, RD; Ferraro, F; Paschalaki, KE; Dryden, NH; McKinnon, TAJ; Sutton, RE; Payne, EM; (2011) Endothelial von Willebrand factor regulates angiogenesis. BLOOD , 117 (3) 1071 - 1080. 10.1182/blood-2010-01-264507.

Steele, AJ; Prentice, AG; Last, V; Hoffbrand, AV; Wickremasinghe, RG; (2011) The p90RSK Inhibitor BI-D1870 Induces Apoptosis in CLL Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1067). AMER SOC HEMATOLOGY

Stephens, PJ; Greenman, CD; Fu, B; Yang, F; Bignell, GR; Mudie, LJ; Pleasance, ED; (2011) Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development. CELL , 144 (1) pp. 27-40. 10.1016/j.cell.2010.11.055.

Strenger, V; Pfurtscheller, K; Wendelin, G; Aberle, SW; Nacheva, EP; Zohrer, B; Zenz, W; (2011) Differentiating Inherited Human Herpesvirus Type 6 Genome from Primary Human Herpesvirus Type 6 Infection by Means of Dried Blood Spot from the Newborn Screening Card. J PEDIATR-US , 159 (5) 859 - 861. 10.1016/j.jpeds.2011.06.032.

Strenger, V; Urban, C; Schwinger, W; Nacheva, EP; Aberle, SW; (2011) Transmission of Chromosomally Integrated HHV-6 by Bone Marrow Transplantation. PEDIATR BLOOD CANCER , 56 (1) 171 - 171. 10.1002/pbc.22828.

Stuart, GCE; Kitchener, H; Bacon, M; duBois, A; Friedlander, M; Ledermann, J; Marth, C; (2011) 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 (4) pp. 750-755. 10.1097/IGC.0b013e31821b2568.

Sun, Y; Hu, J; Zhou, L; Pollard, SM; Smith, A; (2011) Interplay between FGF2 and BMP controls the self-renewal, dormancy and differentiation of rat neural stem cells. J Cell Sci , 124 (Pt 11) pp. 1867-1877. 10.1242/jcs.085506.

Surinova, S; Schiess, R; Hüttenhain, R; Cerciello, F; Wollscheid, B; Aebersold, R; (2011) On the development of plasma protein biomarkers. J Proteome Res , 10 (1) pp. 5-16. 10.1021/pr1008515.

T

Taner, SB; Pando, MJ; Roberts, A; Schellekens, J; Marsh, SG; Malmberg, KJ; Parham, P; (2011) Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol , 186 (1) pp. 62-72. 10.4049/jimmunol.0903657.

Taveirne, S; De Colvenaer, V; Van Den Broeck, T; Van Ammel, E; Bennett, CL; Taghon, T; Vandekerckhove, B; (2011) Langerhans cells are not required for epidermal V gamma 3 T cell homeostasis and function. J LEUKOCYTE BIOL , 90 (1) 61 - 68. 10.1189/jlb.1010581.

Taylor, RM; Fern, L; Whelan, J; Pearce, S; Grew, T; Millington, H; Ashton, J; (2011) "Your Place or Mine?'' Priorities for a Specialist Teenage and Young Adult (TYA) Cancer Unit: Disparity Between TYA and Professional Perceptions. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY , 1 (3) pp. 145-151. 10.1089/jayao.2011.0037.

Taylor, RM; Grieve, A; Gibson, F; Dhawan, A; Franck, LS; (2011) Parental assessment of adolescent quality of life: can it replace self-assessment? QUALITY OF LIFE RESEARCH , 20 (10) pp. 1715-1720. 10.1007/s11136-011-9904-9.

Thirlwell, C; Schulz, LKE; Dibra, HK; Beck, S; (2011) Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy. CLINICAL EPIGENETICS , 3 (ARTN 9) 10.1186/1868-7083-3-9.

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell activating factor is elevated in acute idiopathic thrombotic thrombocytopenic purpura. BRITISH JOURNAL OF HAEMATOLOGY , 155 (5) pp. 620-622. 10.1111/j.1365-2141.2011.08730.x.

Tsochatzis, EA; Germani, G; Dhillon, AP; Burroughs, AK; (2011) Noninvasive Assessment of Liver Fibrosis: the Clinical Context and Question are Important. HEPATOLOGY , 54 (6) p. 2276. 10.1002/hep.24566.

Tsochatzis, EA; Germani, G; Hall, A; Anousou, PM; Dhillon, AP; Burroughs, AK; (2011) Noninvasive Assessment of Liver Fibrosis: The Need for Better Validation. HEPATOLOGY , 53 (5) 1781 - 1782. 10.1002/hep.24271.

Tsochatzis, EA; Manousou, P; Fede, G; Dhillon, AP; Burroughs, AK; (2011) Validating non-invasive markers of fibrosis: the need for a new histological reference standard. GUT , 60 (10) 1442 - 1443. 10.1136/gut.2010.229484.

Tsogka, E; Brazma, D; Howard-Reeves, J; Grace, C; Nacheva, EP; (2011) MOLECULAR Karyotyping In CLL - COST Neutral Alternative to FISH SCREENING for Detection of Clinically Relevant Genome Imbalances. Presented at: UNSPECIFIED.

Tsui, NB; Kadir, RA; Chan, KC; Chi, C; Mellars, G; Tuddenham, EG; Leung, TY; (2011) Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood , 117 (13) pp. 3684-3691. 10.1182/blood-2010-10-310789.

Tudzarova, S; Colombo, SL; Stoeber, K; Carcamo, S; Williams, GH; Moncada, S; (2011) Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. P NATL ACAD SCI USA , 108 (13) 5278 - 5283. 10.1073/pnas.1102247108. Gold open access

V

Vaughan, S; Coward, JI; Bast, RC; Berchuck, A; Berek, JS; Brenton, JD; Coukos, G; (2011) Rethinking ovarian cancer: recommendations for improving outcomes. NAT REV CANCER , 11 (10) 719 - 725. 10.1038/nrc3144.

Velica, P; Bunce, CM; (2011) A QUICK, SIMPLE AND UNBIASED METHOD TO QUANTIFY C2C12 MYOGENIC DIFFERENTIATION. MUSCLE NERVE , 44 (3) 366 - 370. 10.1002/mus.22056.

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; Inusa, B; (2011) Long-term safety and efficacy of deferasirox (Exjade (R)) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. BRIT J HAEMATOL , 154 (3) 387 - 397. 10.1111/j.1365-2141.2011.08720.x.

Vichinsky, EP; Ohene-Frempong, K; Thein, SL; Lobo, CLD; Inati, A; Thompson, AA; Smith-Whitley, K; (2011) Transfusion and Chelation Practices in Sickle Cell Disease: A Regional Perspective. PEDIATR HEMAT ONCOL , 28 (2) 124 - 133. 10.3109/08880018.2010.505506.

Vilella, AJ; Birney, E; Flicek, P; Herrero, J; (2011) Considerations for the inclusion of 2x mammalian genomes in phylogenetic analyses. Genome Biology , 12 , Article 401. 10.1186/gb-2011-12-2-401. Green open access

Virgili, A; Koptyra, M; Dasgupta, Y; Glodkowska-Mrowka, E; Stoklosa, T; Nacheva, EP; Skorski, T; (2011) Imatinib Sensitivity in BCR-ABL1-Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele. CANCER RES , 71 (16) 5381 - 5386. 10.1158/0008-5472.CAN-11-0068.

Visone, R; Veronese, A; Rassenti, LZ; Balatti, V; Pearl, DK; Acunzo, M; Volinia, S; (2011) miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. BLOOD , 118 (11) 3072 - 3079. 10.1182/blood-2011-01-333484.

Vladimirou, E; Harry, E; Burroughs, N; McAinsh, AD; (2011) Springs, clutches and motors: driving forward kinetochore mechanism by modelling. Chromosome Res , 19 (3) pp. 409-421. 10.1007/s10577-011-9191-x.

van Zyl-Smit, RN; Binder, A; Meldau, R; Mishra, H; Semple, PL; Theron, G; Peter, J; (2011) Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden. PLOS ONE , 6 (12) , Article e28815. 10.1371/journal.pone.0028815. Green open access
file

von Minckwitz, G; Schwedler, K; Schmidt, M; Barinoff, J; Mundhenke, C; Cufer, T; Maartense, E; (2011) Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer. Eur J Cancer , 47 (15) pp. 2273-2281. 10.1016/j.ejca.2011.06.021.

W

Wan, SG; Taccioli, C; Jiang, YB; Chen, HP; Smalley, KJ; Huang, K; Liu, XP; (2011) Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. INT J CANCER , 129 (2) 331 - 345. 10.1002/ijc.25688.

Wang, AT; Sengerova, B; Cattell, E; Inagawa, T; Hartley, JM; Kiakos, K; Burgess-Brown, NA; (2011) Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. GENE DEV , 25 (17) 1859 - 1870. 10.1101/gad.15699211.

Wang, D; Liu, F; Wang, L; Huang, S; Yu, J; (2011) Nonsynonymous substitution rate (Ka) is a relatively consistent parameter for defining fast-evolving and slow-evolving protein-coding genes. Biol Direct , 6 13-. 10.1186/1745-6150-6-13.

Wang, D; Yu, J; (2011) Both size and GC-content of minimal introns are selected in human populations. PLoS One , 6 (3) , Article e17945. 10.1371/journal.pone.0017945.

Wang, XD; Lapi, E; Sullivan, A; Ratnayaka, I; Goldin, R; Hay, R; Lu, X; (2011) SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ , 18 (2) pp. 304-314. 10.1038/cdd.2010.101.

Ward, NJ; Buckley, SMK; Waddington, SN; VandenDriessche, T; Chuah, MKL; Nathwani, AC; McIntosh, J; (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. BLOOD , 117 (3) 798 - 807. 10.1182/blood-2010-05-282707.

Wen, PJ; Osborne, SL; Zanin, M; Low, PC; Wang, HT; Schoenwaelder, SM; Jackson, SP; (2011) Phosphatidylinositol(4,5)bisphosphate coordinates actin-mediated mobilization and translocation of secretory vesicles to the plasma membrane of chromaffin cells. Nat Commun , 2 491-. 10.1038/ncomms1500.

Westbury, CB; Sahlberg, KK; Borresen-Dale, AL; Isacke, CM; Yarnold, JR; (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42. Gold open access

Westin, J; Hellstrand, K; Dhillon, AP; Lagging, M; DITTO-HCV Study Grp, ; (2011) Are FoxP3+cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? J VIRAL HEPATITIS , 18 (2) 149 - 151. 10.1111/j.1365-2893.2010.01277.x.

Whiteford, JR; Xian, X; Chaussade, C; Vanhaesebroeck, B; Nourshargh, S; Couchman, JR; (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell , 22 (19) pp. 3609-3624. 10.1091/mbc.E11-02-0099.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. BRIT J HAEMATOL , 153 (5) 545 - 556. 10.1111/j.1365-2141.2011.08676.x.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. LEUKEMIA , 25 (9) 1400 - 1407. 10.1038/leu.2011.103.

Wilkerson, PM; Dedes, KJ; Wetterskog, D; Mackay, A; Lambros, MB; Mansour, M; Frankum, J; (2011) Functional characterization of EMSY gene amplification in human cancers. J Pathol , 225 (1) pp. 29-42. 10.1002/path.2944.

Y

Yi, JM; Dhir, M; Van Neste, L; Downing, SR; Jeschke, J; Glockner, SC; Calmon, MD; (2011) Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer. CLIN CANCER RES , 17 (6) 1535 - 1545. 10.1158/1078-0432.CCR-10-2509.

Young, RJ; Tin, A; Brown, NJ; Staton, C; Lee, SM; Jital, M; Woll, P; (2011) SERUM BIOMARKERS IN LUNG CANCER PATIENTS FROM TWO CLINICAL TRIALS OF CHEMOTHERAPY WITH OR WITHOUT THALIDOMIDE. JOURNAL OF THORACIC ONCOLOGY , 6 (6) S1058-S1059.

Z

Zhang, EZ; Povazay, B; Laufer, J; Alex, A; Hofer, B; Pedley, B; Glittenberg, C; (2011) Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. BIOMEDICAL OPTICS EXPRESS , 2 (8) pp. 2202-2215.

Zhang, L; Chari, S; Smyrk, TC; Deshpande, V; Kloeppel, G; Kojima, M; Liu, X; (2011) Autoimmune Pancreatitis (AIP) Type 1 and Type 2 An International Consensus Study on Histopathologic Diagnostic Criteria. PANCREAS , 40 (8) pp. 1172-1179. 10.1097/MPA.0b013e318233bec5.

Zhang, Q; Wang, H; Kantekure, K; Paterson, JC; Liu, X; Schaffer, A; Paulos, C; (2011) Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. BLOOD , 118 (11) pp. 3062-3071. 10.1182/blood-2011-01-332916.

Zhou, YP; Adolfs, Y; Pijnappel, WWMP; Fuller, SJ; Van der Schors, RC; Li, KW; Sugden, PH; (2011) MICAL-1 Is a Negative Regulator of MST-NDR Kinase Signaling and Apoptosis. MOL CELL BIOL , 31 (17) 3603 - 3615. 10.1128/MCB.01389-10.

Zweifel, M; Jayson, GC; Reed, NS; Osborne, R; Hassan, B; Ledermann, J; Shreeves, G; (2011) Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. ANNALS OF ONCOLOGY , 22 (9) pp. 2036-2041. 10.1093/annonc/mdq708.

This list was generated on Sun Dec 4 06:32:27 2016 GMT.